Home > Journals > Minerva Pediatrica > Past Issues > Minerva Pediatrica 2018 February;70(1) > Minerva Pediatrica 2018 February;70(1):59-66

CURRENT ISSUE
 

ARTICLE TOOLS

Publication history
Reprints
Cite this article as

MINERVA PEDIATRICA

A Journal on Pediatrics, Neonatology, Adolescent Medicine,
Child and Adolescent Psychiatry


Indexed/Abstracted in: CAB, EMBASE, PubMed/MEDLINE, Science Citation Index Expanded (SciSearch), Scopus
Impact Factor 0,764


eTOC

 

REVIEW  


Minerva Pediatrica 2018 February;70(1):59-66

DOI: 10.23736/S0026-4946.17.05147-7

Copyright © 2017 EDIZIONI MINERVA MEDICA

language: English

Safety of HPV vaccines in the age of nonavalent vaccination

Filippo QUATTRONE , Alice CANALE, Elisa FILIPPETTI, Alberto TULIPANI, Andrea PORRETTA, Pier L. LOPALCO

Unit of Hygiene and Epidemiology, Department of Translational Research, New Technologies in Medicine and Surgery, University of Pisa, Pisa, Italy


PDF  


To date three vaccines against human papilloma virus (HPV) have been licensed: a bivalent, a quadrivalent and, in 2014, a nonavalent vaccine. Despite the early implementation of national vaccination programs, in the majority of developed countries coverage rates remain unsatisfactory. Rumors about vaccine safety have been one of the principal obstacles for the acceptance of HPV vaccination by the public. It is therefore of primary importance to provide the public with clear and up-to-date information about HPV vaccination safety. To this aim, in this narrative review we will summarize safety data from pre and postlicensure studies for the three HPV vaccines available with a focus on the safety profile of the new nonavalent vaccine.


KEY WORDS: Papillomavirus vaccines - Vaccines - Review

top of page

Publication History

Issue published online: January 12, 2018
Manuscript accepted: December 6, 2017
Manuscript received: November 17, 2017

Cite this article as

Quattrone F, Canale A, Filippetti E, Tulipani A, Porretta A, Lopalco PL. Safety of HPV vaccines in the age of nonavalent vaccination. Minerva Pediatr 2018;70:59-66. DOI: 10.23736/S0026-4946.17.05147-7

Corresponding author e-mail

filippo.quattrone@med.unipi.it